Aortix is a circulatory support device for chronic heart failure patients on medical management who have been hospitalized for acute decompensated heart failure (ADHF) and have persistent congestion despite usual medical therapy. Eligible ADHF patients with diuretic resistance (irrespective of ejection fraction) will be enrolled and randomized 1:1 to either the Aortix system or standard of care medical management.
Heart Failure, Cardiorenal Syndrome, Cardio-Renal Syndrome, ADHF, Heart Failure, Systolic, Heart Failure, Diastolic, Heart Failure; with Decompensation, Heart Failure, Congestive
Aortix is a circulatory support device for chronic heart failure patients on medical management who have been hospitalized for acute decompensated heart failure (ADHF) and have persistent congestion despite usual medical therapy. Eligible ADHF patients with diuretic resistance (irrespective of ejection fraction) will be enrolled and randomized 1:1 to either the Aortix system or standard of care medical management.
Diuretics Alone Vs. Aortix Endovascular Device for Acute Heart Failure
-
Birmingham VA Health Care System, Birmingham, Alabama, United States, 35233
Banner--University Medical Center Phoenix, Phoenix, Arizona, United States, 85006
HonorHealth Medical Center, Scottsdale, Arizona, United States, 85258
John Muir Health, Concord, California, United States, 94520
Zuckerberg San Francisco General, San Francisco, California, United States, 94110
San Francisco Veterans Administration, San Francisco, California, United States, 94121
University of California San Francisco, San Francisco, California, United States, 94143
Ascension Sacred Heart, Pensacola, Florida, United States, 32504
Tallahassee Research Institute, Tallahassee, Florida, United States, 32308
University of South Florida, Tampa, Florida, United States, 33606
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
For general information about clinical research, read Learn About Studies.
21 Years to
ALL
No
Procyrion,
2025-12